The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism

OBJECTIVES: The aim of this study was to evaluate the efficiency of cetuximab-based anti-EGFR treatment and Aurora kinase A / B knockdown as a function of Aurora kinase polymorphism in HNSCC cell lines. MATERIALS AND METHODS: First, protein expression of Aurora kinase A / B and EGFR and Aurora kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickhard, Anja, Siegl, Michael, Baumann, Alexander, Huhn, Maximilian, Wirth, Markus, Reiter, Rudolf, Rudelius, Martina, Piontek, Guido, Brockhoff, Gero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170642/
https://www.ncbi.nlm.nih.gov/pubmed/24980817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170642/
https://www.ncbi.nlm.nih.gov/pubmed/24980817

Ejemplares similares